Neo Ivy Capital Management Abiomed Inc Transaction History

Neo Ivy Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 17, 2020	SELL	$255.22 - $317.0 $187,076 - $232,361	-733 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$141.4 - $257.09 $41,995 - $76,355	297 Added 68.12%	733 $177,000
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $4,045 - $6,076	31 Added 7.65%	436 $63,000
Q4 2019 Feb 13, 2020	BUY	$159.31 - $223.54 $64,520 - $90,533	405 New	405 $69,000
Q3 2019 Nov 21, 2019	SELL	$175.89 - $279.23 $128,927 - $204,675	-733 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$250.96 - $284.94 $939,092 - $1.07 Million	-3,742 Reduced 83.62%	733 $191,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $1.24 Million - $1.62 Million	4,475 New	4,475 $1.28 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.